Krystal Biotech
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $83,841 | $70,284 | $45,250 | $42,143 |
Gross Profit | 77,157 | 62,289 | 42,831 | 37,765 |
EBITDA | 31,257 | 18,031 | 2,541 | 12,164 |
EBIT | 29,728 | 16,045 | 932 | 10,657 |
Net Income | 27,180 | 15,568 | 932 | 8,692 |
Net Change In Cash | 83,841 | 70,284 | 45,250 | 42,143 |
Free Cash Flow | 57,811 | -5,299 | 14,628 | -9,079 |
Cash | 373,966 | 345,786 | 359,006 | 358,328 |
Basic Shares | 29,902 | 29,637 | 29,291 | 28,817 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $50,699 | $0 | $0 | $0 |
Gross Profit | 47,605 | -4,054 | -2,769 | -1,851 |
EBITDA | 17,904 | -145,196 | -65,309 | -30,316 |
EBIT | 12,897 | -149,250 | -68,078 | -32,167 |
Net Income | 10,932 | -139,975 | -69,570 | -32,167 |
Net Change In Cash | 50,699 | 0 | 0 | 0 |
Cost of Revenue | 72,977 | 80,755 | ||
Free Cash Flow | -100,603 | -153,548 | -116,274 | -40,926 |
Cash | 358,328 | 161,900 | 341,246 | 268,269 |
Basic Shares | 27,751 | 25,491 | 22,196 | 18,787 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.91 |
2024-06-30 | $0.53 |
2024-03-31 | $0.03 |
2023-12-31 | $0.30 |
